§1 coupon per prescription.
Also valid on refills.
Also valid on refills.
Printer-friendly version
Return to RELPAX.com
To view the patient information for RELPAX, click on the link below.
View patient informationTo view PDF documents, you must have Adobe® Reader® installed on your computer. If you do not have Adobe Reader, download it from the Adobe Web site.
By clicking on the link, you will be leaving this Pfizer site.*
Back to previous page
*Links to other sites are provided as a convenience to the viewer. Pfizer accepts
no responsibility for the content of linked sites.
Adobe, the Adobe logo, and Reader are registered trademarks of Adobe Systems Incorporated in the United States and/or other countries.
Adobe, the Adobe logo, and Reader are registered trademarks of Adobe Systems Incorporated in the United States and/or other countries.
Important safety information
RELPAX is indicated for the acute treatment of migraine with or without aura in adults. Only your doctor can decide if RELPAX is right for you.
RELPAX should be taken as a single 40-mg tablet. If needed, and as directed by your healthcare professional, an additional 40-mg tablet can be taken at least 2 hours later. No more than two 40-mg tablets should be taken in any 24-hour period.
Most common side effects are dizziness, nausea, weakness, feeling sleepy, pain or pressure sensation in the chest or throat. Tell your doctor about any side effects you have.
If you have certain types of heart disease, a history of stroke, TIA, or uncontrolled blood pressure, you should not take RELPAX. Very rarely, certain people, even some without heart disease, have had serious heart-related problems. Talk to your doctor if you have risk factors for heart disease such as smoking, high blood pressure or high cholesterol, or if you are pregnant or nursing.
RELPAX, as with other drugs in its class (triptans), can cause serotonin syndrome, particularly when used with certain medications (SSRIs and SNRIs) commonly used to treat depression.
RELPAX should not be used within at least 72 hours of treatment with the following medicines: Nizoral®, Sporanox®, Serzone®, TAO®, Biaxin®, Norvir®, and Viracept®.
All brands are trademarks of their owners.
Click here for RELPAX prescribing information.
The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a health care provider. All decisions regarding patient care must be made with a health care provider, considering the unique characteristics of the patient.
The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.
RELPAX is indicated for the acute treatment of migraine with or without aura in adults. Only your doctor can decide if RELPAX is right for you.
RELPAX should be taken as a single 40-mg tablet. If needed, and as directed by your healthcare professional, an additional 40-mg tablet can be taken at least 2 hours later. No more than two 40-mg tablets should be taken in any 24-hour period.
Most common side effects are dizziness, nausea, weakness, feeling sleepy, pain or pressure sensation in the chest or throat. Tell your doctor about any side effects you have.
If you have certain types of heart disease, a history of stroke, TIA, or uncontrolled blood pressure, you should not take RELPAX. Very rarely, certain people, even some without heart disease, have had serious heart-related problems. Talk to your doctor if you have risk factors for heart disease such as smoking, high blood pressure or high cholesterol, or if you are pregnant or nursing.
RELPAX, as with other drugs in its class (triptans), can cause serotonin syndrome, particularly when used with certain medications (SSRIs and SNRIs) commonly used to treat depression.
RELPAX should not be used within at least 72 hours of treatment with the following medicines: Nizoral®, Sporanox®, Serzone®, TAO®, Biaxin®, Norvir®, and Viracept®.
All brands are trademarks of their owners.
Click here for RELPAX prescribing information.
The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a health care provider. All decisions regarding patient care must be made with a health care provider, considering the unique characteristics of the patient.
The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.
|
 |
